GE To Enter China’s Medical Home Care Market
This article was originally published in PharmAsia News
GE Healthcare has announced it will introduce home respiratory and sleep care solutions into China's homes. The Vivo series of electronic ventilators and non-invasive iSleep devices used for home respiratory support and sleep apnea come from Vital Signs and its subsidiary Breas Medical, which were acquired by GE a few years ago. The move represents the firm's first foray into the country's medical home care market, giving it direct access to patients. GE Healthcare sees home health care as an emerging sector with rapid growth and China offers huge market potential. (Click here for more - Chinese Language)
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.